View All Key Stats
VVUS Key Stats
| Income Statement | |
| Revenue (TTM) | 65.37M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.30 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -30.51M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 67.04% |
| Profit Margin (Quarterly) | -84.37% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 40.83M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 0.6229 |
| PE Ratio (TTM) | -- |
| Price to Book Value | -- |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -4.879M |
| Return on Equity (TTM) | Upgrade |
View All VVUS News
VVUS News
-
WireHeadlineTime (ET)
-
Yahoo04/12 09:50
-
PR Newswire03/16 09:25
-
SA Breaking News03/13 16:22
-
Yahoo03/13 16:15
-
Marketwired03/13 16:05
-
Yahoo02/09 08:30
-
SA Breaking News12/26 16:15
-
MT Newswires12/26 16:12
-
Marketwired12/26 16:05
-
Marketwired11/07 16:05
View All Events
VVUS Events
| Date | Type | Description |
|---|---|---|
| 03/19/2018 | Misc | VIVUS Inc Fourth Quarter Earnings Conference Call in 2017 |
| 03/19/2018 | Earnings | VIVUS Inc Fourth Quarter Earnings Results in 2017 |
| 11/07/2017 16:30 EDT | Misc | VIVUS Inc Third Quarter Earnings Conference Call in 2017 |
| 11/07/2017 | Earnings | VIVUS Inc Third Quarter Earnings in 2017 Release |
| 10/27/2017 | Misc | VIVUS Inc Annual General Meeting in 2016 |
| 08/03/2017 | Earnings | VIVUS Inc Second Quarter Earnings Results in 2017 |
| 05/03/2017 16:30 EDT | Misc | VIVUS Inc First Quarter Earnings Conference Call in 2017 |
| 05/03/2017 | Earnings | VIVUS Inc First Quarter Earnings in 2017 Release |
VVUS Fundamentals
Income Statement View Statement
VVUS Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
VVUS One Page Reports
- One Page Report Download
VVUS Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 0.3851 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.vivus.com
- Investor Relations URL: http://ir.vivus.com/
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Blend
- Next Earnings Release: N/A
- Last Earnings Release: Mar. 19, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: VIVUS Incis a biopharmaceutical company engaged in the development and commercialization of therapeutic products for large underserved markets. Its product line includes Qsymia for sleep apnea, STENDRA for erectile dysfunction.
VVUS Excel Add-In Codes
- Name: =YCI("VVUS","name")
- Description: =YCI("VVUS","description")
- Sector: =YCI("VVUS","sector")
- Industry: =YCI("VVUS","industry")
- Est. Current Fiscal Year End: =YCI("VVUS","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other VVUS Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- VVUS Tweets Stocktwits
Advertisement
